Interferon alpha-2a biosimilar (Hainan Xinmingda)

干扰素α-2a生物类似药 (海南欣明达)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameInterferon alpha-2a biosimilar (Hainan Xinmingda)
Drug Alias Name干扰素α-2a生物仿制药 (欣明达)贝尔芬r-hu-IFNa2
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokinesBiologics > Biosimilar
Mechanisms of ActionImmunomodulatorsInnate antiviral immune response inducersInterferon alpha/beta receptor agonists
TargetsInterferon alpha/beta receptor
Therapy Area/IndicationsNeoplasmsInfections
Global Approved IndicationsNeoplasmsInfections
Approved Indications in ChinaNeoplasmsInfections
Original Approved Country/TerritoryMainland China
Original Approved Date1999/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesHainan Xinmingda Bio- Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHainan Xinmingda Bio- Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasmsInfections
Inactive IndicationsN/A

Other Information

ATC CodeL03AB04
Related LinksN/A